Rapport Therapeutics
Trade Rapport Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About RAPP
Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform.
RAPP Key Statistics
Stock Snapshot
With a market cap of 1.32B, Rapport Therapeutics(RAPP) trades at $27.62. The stock has a price-to-earnings ratio of -9.64.
On 2026-03-17, Rapport Therapeutics(RAPP) shares started trading at $27.93, with intraday highs of — and lows of —.
Trading volume for Rapport Therapeutics(RAPP) stock has reached 0, versus its average volume of 407.54K.
Over the past 52 weeks, Rapport Therapeutics(RAPP) stock has traded between a high of $42.27 and a low of $7.73.
Over the past 52 weeks, Rapport Therapeutics(RAPP) stock has traded between a high of $42.27 and a low of $7.73.
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.